{"pmid":32389721,"title":"Tocilizumab in COVID-19: beware of risk of intestinal perforation.","text":["Tocilizumab in COVID-19: beware of risk of intestinal perforation.","Int J Antimicrob Agents","Vikse, Jens","Henry, Brandon Michael","32389721"],"journal":"Int J Antimicrob Agents","authors":["Vikse, Jens","Henry, Brandon Michael"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32389721","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.ijantimicag.2020.106009","e_drugs":["tocilizumab"],"topics":["Treatment"],"weight":1,"_version_":1666528580093345792,"score":9.490897,"similar":[{"pmid":32402416,"title":"Intestinal perforation in patient with COVID-19 infection treated with tocilizumab and corticosteroids. Report of a clinical case.","text":["Intestinal perforation in patient with COVID-19 infection treated with tocilizumab and corticosteroids. Report of a clinical case.","Cir Esp","Gonzalvez Guardiola, Paula","Diez Ares, Jose Angel","Peris Tomas, Nuria","Sebastian Tomas, Juan Carlos","Navarro Martinez, Sergio","32402416"],"journal":"Cir Esp","authors":["Gonzalvez Guardiola, Paula","Diez Ares, Jose Angel","Peris Tomas, Nuria","Sebastian Tomas, Juan Carlos","Navarro Martinez, Sergio"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32402416","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.ciresp.2020.04.030","topics":["Case Report"],"weight":1,"_version_":1666714494920818690,"score":61.12258}]}